No information is available for Reference: Apricitabine does not select additional drug resistance mutations in tissue culture in human immunodeficiency virus type 1 variants containing K65R, M184V, or M184V plus thymidine analogue mutations.
No data from this paper has been entered yet. You can create an account to enter it right now if you like.
We welcome new collaborators! Get started by creating an account and entering some data. Please contact us if you would like to contribute more than a few references.